Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer

NCT07646301 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cervical Neoplasms
Locally Advanced

Interventions

DRUG: Iparomlimab and Tuvonralimab (QL1706)
DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Carboplatin

Sponsor

Sun Yat-sen University